Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook

More articles from Commentary

  • You have access
    Challenges and Solutions to Manufacturing of Low-Viscosity, Ultra-High Concentration IgG1 Drug Products: From Late Downstream Process to Final Fill Finish Processing
    Vaibhav Deokar, Alok Sharma and Subrahmanyam M. Volety
    PDA Journal of Pharmaceutical Science and Technology March 2025, 79 (2) 218-235; DOI: https://doi.org/10.5731/pdajpst.2023.012873
  • You have access
    Retrospective Evaluation of Cycled Resin in Viral Clearance Studies - A Multiple Company Collaboration - Post ICH Q5A(R2) Review
    Jennifer Anderson, Chelsea Burgwin and Donna Hamilton
    PDA Journal of Pharmaceutical Science and Technology April 2025, pdajpst.2024-003024; DOI: https://doi.org/10.5731/pdajpst.2024-003024.1
  • You have access
    Addressing Medical Device Extractables and Leachables via Non-Target Analysis (NTA); The Analytical Evaluation Threshold (AET) and Quantitation
    Dennis Jenke, Piet Christiaens and Ted Heise
    PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 98-113; DOI: https://doi.org/10.5731/pdajpst.2024.012945
  • You have access
    Expanding the Use of Moist Heat for Terminal Sterilization
    James Agalloco
    PDA Journal of Pharmaceutical Science and Technology January 2025, 79 (1) 114-121; DOI: https://doi.org/10.5731/pdajpst.2023.012918
  • You have access
    A Commentary on “Understanding the Non-Equivalency of Bio-Fluorescent Particle Counts versus the Colony Forming Unit”
    Félix A. Montero Julian
    PDA Journal of Pharmaceutical Science and Technology November 2024, 78 (6) 730-734; DOI: https://doi.org/10.5731/pdajpst.2024.012995
  • You have access
    A Strategic Guide to Improve and De-Risk Vaccine Development: CEPI’s CMC Framework
    Anna Särnefält, Ranna Eardley-Patel, Diletta Magini, Vishal Sonje, Antonio Guzzi, Renske Hesselink, Matthew Scotney, Alessandro Lazdins, Valerie Chambard, Christof Vinnemeier and Ingrid Kromann
    PDA Journal of Pharmaceutical Science and Technology September 2024, 78 (5) 613-623; DOI: https://doi.org/10.5731/pdajpst.2023.012912
  • You have access
    Demonstrating Results Equivalence of Bacterial Endotoxins Test Methods
    Steven Walfish, John Duguid and Karen McCullough
    PDA Journal of Pharmaceutical Science and Technology July 2024, 78 (4) 501-511; DOI: https://doi.org/10.5731/pdajpst.2023.012871
  • You have access
    Accurate or Protective: What Is the Goal of Non-Targeted Extractables and Leachables Quantitation and Identification?
    Dennis Jenke
    PDA Journal of Pharmaceutical Science and Technology May 2024, 78 (3) 358-366; DOI: https://doi.org/10.5731/pdajpst.2023.012868
  • You have access
    Biocompatibility Considerations for Orally Inhaled and Nasal Drug Products and Other Drug-–Device Combination Products
    Cheryl L. M. Stults, Christine L. Lanning, Lee M. Nagao and James Conners
    PDA Journal of Pharmaceutical Science and Technology January 2024, 78 (1) 125-139; DOI: https://doi.org/10.5731/pdajpst.2023.012852
  • You have access
    Understanding the Non-Equivalency of Bio-Fluorescent Particle Counts versus the Colony-Forming Unit
    Joanny Salvas, Petra Merker, Mike Dingle, Cedric Joossen, Chris Knutsen, David Govezensky, Jim Cannon, Philip Villari, Anthony Cundell, Victoria Navarro, Margit Franz-Riethdorf and Allison Scott
    PDA Journal of Pharmaceutical Science and Technology November 2023, 77 (6) 514-518; DOI: https://doi.org/10.5731/pdajpst.2022.012790

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 32

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire